Joni Henderson

Joni Henderson is the Senior Director of Corporate Communications and Strategic Growth at C2N Diagnostics, a company focused on developing advanced brain health diagnostics.12 Here are some key details about her background and role:

Professional Experience

• Current Role: Senior Director, Corporate Communications and Strategic Growth at C2N Diagnostics since 20201
• Previous Positions:
  • President of Blue Zone Strategies, LLC (2019-2020)
  • Vice President of Corporate Education Partnerships at Discovery Communications (2010-2017)
  • Vice President of Communications, Marketing & Development at National Board for Professional Teaching Standards (2002-2010)

Expertise and Achievements

• Over 25 years of experience in partnership, business, and program development with globally recognized organizations3
• Led the public launch of PrecivityAD, the first widely-accessible blood test for Alzheimer's disease, at C2N Diagnostics1
• Created numerous national initiatives in healthcare and education sectors, including:
  • First-of-its-kind transportation programs for clinical trial participants
  • National Citizen Scientist Awards for clinical trial volunteers
• Developed award-winning global K-12 educational initiatives with Fortune 500 companies on subjects like STEM, online safety, and health awareness3

Education

• Master of Science in Non-Profit Administration from Drexel University
• Bachelor of Arts in Business Administration from University of Redlands14

Role at C2N Diagnostics

At C2N Diagnostics, Joni Henderson is responsible for:

• Handling all marketing, outreach, communications, and partnership development
• Commercializing C2N's PrecivityAD blood detection test for Alzheimer's
• Building partnerships and securing funding agreements with various organizations, including Fortune 500 companies, government agencies, non-profits, and foundations1

Henderson's extensive experience in partnership development and communications makes her a valuable asset to C2N Diagnostics as they work to expand their presence in the brain health diagnostics field.